Marco Bo Hansen

Marco Bo Hansen

Auto-generated profile, based on publicly available information

Marco Bo Hansen

Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2019 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
IGINFECT study group
INFECT study group
MMMartin Bruun Madsen
Martin Bruun Madsen
SSSteinar Skrede
Steinar Skrede
APAnders Perner
Anders Perner
PAPer Arnell
Per Arnell
OHOle Hyldegaard
Ole Hyldegaard

18 April 2017 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
MMMartin B. Madsen
Martin B. Madsen
PHPeter B. Hjortrup
Peter B. Hjortrup
MHMarco B. Hansen
Marco B. Hansen
TLTheis Lange
Theis Lange
ANAnna Norrby-Teglund
Anna Norrby-Teglund
APAnders Perner
Anders Perner

1 November 2015 in Resuscitation
Verified
Journal Article
Open access
MAMarianne Agerskov
Marianne Agerskov
ANAnne Møller Nielsen
Anne Møller Nielsen
CHCarolina Malta Hansen
Carolina Malta Hansen
MHMarco Bo Hansen
Marco Bo Hansen
FLFreddy Knudsen Lippert
Freddy Knudsen Lippert
LRLars Simon Rasmussen
Lars Simon Rasmussen
In Copenhagen, a volunteer-based Automated External Defibrillator (AED) network provides a unique opportunity to assess AED use. We aimed to determine the proportion of Out-of-Hospital Cardiac Arrest (OHCA) where an AED was applied before arrival of the ambulance, and the proportion of OHCA-cases where an accessible AED was located within 100 m. In addition, we assessed 30-day survival. Using data from the Mobile Emergency Care Unit and the Danish Cardiac Arrest Registry, we identified 521 patients with OHCA between October 1, 2011 and September 31, 2013 in Copenhagen, Denmark. An AED was applied in 20 cases (3.8%, 95% CI [2.4 to 5.9]). Irrespective of AED accessibility, an AED was located within 100 m of a cardiac arrest in 23.4% (n=102, 95% CI [19.5 to 27.7]) of all OHCAs. However, at the time of OHCA, an AED was located within 100 m and accessible in only 15.1% (n=66, 95% CI [11.9 to 18.9]) of all cases. The 30-day survival for OHCA with an initial shockable rhythm was 64% for patients where an AED was applied prior to ambulance arrival and 47% for patients where an AED was not applied. We found that 3.8% of all OHCAs had an AED applied prior to ambulance arrival, but 15.1% of all OHCAs occurred within 100 m of an accessible AED. This indicates the potential of utilising AED networks by improving strategies for AED accessibility and referring bystanders of OHCA to existing AEDs.

1 September 2021 in American Journal of Infection Control
Verified
Journal Article
Closed access
MSMarie Stangerup
Marie Stangerup
MHMarco B. Hansen
Marco B. Hansen
RHRosa Hansen
Rosa Hansen
LSLouise P. Sode
Louise P. Sode
BHBjørn Hesselbo
Bjørn Hesselbo
HCHenrik Calum
Henrik Calum

8 February 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MHMarco Bo Hansen
Marco Bo Hansen
LRLars Simon Rasmussen
Lars Simon Rasmussen
OHOle Hyldegaard
Ole Hyldegaard
AWAnna Mygind Wahl
Anna Mygind Wahl
MHMorten Hedetoft
Morten Hedetoft
TNTorbjørn Nedrebø
Torbjørn Nedrebø
Early assessment of necrotising soft tissue infection (NSTI) is challenging. Analysis of inflammatory markers could provide important information about disease severity and guide decision making. For this purpose, we investigated the association between cytokine levels and the Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC)-score, disease severity and mortality in NSTI patients. In 159 patients, plasma was analysed for IL-1β, IL-6, IL-10 and TNF-α upon admission. The severity of NSTI was assessed by SAPS, SOFA score, septic shock, microbial aetiology, renal replacement therapy and amputation. We found no significant difference in cytokine levels according to a LRINEC- score above or below 6 (IL-1β: 3.0 vs. 1.3; IL-6: 607 vs. 289; IL-10: 38.4 vs. 38.8; TNF-α: 15.1 vs. 7.8 pg/mL, P > 0.05). Patients with β-haemolytic streptococcal infection had higher level of particularly IL-6. There was no difference in mortality between patients with a LRINEC-score above or below 6. In the adjusted analysis assessing 30-day mortality, the association was strongest for IL-1β (OR 3.86 [95% CI, 1.43-10.40], P = 0.008) and IL-10 (4.80 [1.67-13.78], P = 0.004). In conclusion, we found no significant association between the LRINEC-score and cytokine levels on admission. IL-6 was consistently associated with disease severity, whereas IL-1β had the strongest association with 30-day mortality.

1 May 2020 in American Journal of Infection Control
Verified
Journal Article
Closed access
AIAnne-Mette Iversen
Anne-Mette Iversen
CKChristiane Pahl Kavalaris
Christiane Pahl Kavalaris
RHRosa Hansen
Rosa Hansen
MHMarco Bo Hansen
Marco Bo Hansen
RARebekah Alexander
Rebekah Alexander
SESvend Ellermann-Eriksen
Svend Ellermann-Eriksen